SG Americas Securities LLC Cuts Stock Holdings in Owens & Minor, Inc. (NYSE:OMI)

SG Americas Securities LLC trimmed its position in shares of Owens & Minor, Inc. (NYSE:OMI) by 82.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,557 shares of the company’s stock after selling 30,548 shares during the quarter. SG Americas Securities LLC’s holdings in Owens & Minor were worth $126,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently bought and sold shares of the company. Deerfield Management Company L.P. Series C boosted its holdings in shares of Owens & Minor by 35.6% in the 3rd quarter. Deerfield Management Company L.P. Series C now owns 6,435,000 shares of the company’s stock worth $103,990,000 after buying an additional 1,690,000 shares during the last quarter. FMR LLC boosted its holdings in shares of Owens & Minor by 10.6% in the 3rd quarter. FMR LLC now owns 11,479,209 shares of the company’s stock worth $185,504,000 after buying an additional 1,103,275 shares during the last quarter. Deutsche Bank AG boosted its holdings in shares of Owens & Minor by 278.0% in the 3rd quarter. Deutsche Bank AG now owns 694,248 shares of the company’s stock worth $11,219,000 after buying an additional 510,596 shares during the last quarter. Nuveen Asset Management LLC boosted its holdings in shares of Owens & Minor by 61.8% in the 2nd quarter. Nuveen Asset Management LLC now owns 1,288,925 shares of the company’s stock worth $24,541,000 after buying an additional 492,348 shares during the last quarter. Finally, Alyeska Investment Group L.P. purchased a new position in shares of Owens & Minor in the 1st quarter worth about $20,483,000. 98.04% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, SVP Michael Wayne Lowry sold 10,000 shares of the business’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $25.00, for a total transaction of $250,000.00. Following the completion of the transaction, the senior vice president now owns 71,654 shares of the company’s stock, valued at $1,791,350. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 2.62% of the company’s stock.

Owens & Minor Trading Down 3.5 %

Shares of OMI opened at $23.97 on Thursday. The business’s 50-day moving average price is $24.76 and its 200-day moving average price is $20.72. Owens & Minor, Inc. has a twelve month low of $13.34 and a twelve month high of $28.35. The stock has a market cap of $1.84 billion, a PE ratio of -44.39, a P/E/G ratio of 0.79 and a beta of 0.43. The company has a quick ratio of 0.52, a current ratio of 1.11 and a debt-to-equity ratio of 2.05.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings results on Tuesday, February 20th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.03. Owens & Minor had a positive return on equity of 11.62% and a negative net margin of 0.40%. The firm had revenue of $2.66 billion for the quarter, compared to analysts’ expectations of $2.67 billion. During the same period in the prior year, the business posted $0.28 earnings per share. The company’s revenue was up 4.1% on a year-over-year basis. On average, equities analysts forecast that Owens & Minor, Inc. will post 1.54 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on OMI. TheStreet raised shares of Owens & Minor from a “d+” rating to a “c-” rating in a report on Monday, March 4th. UBS Group lowered their price objective on Owens & Minor from $28.00 to $26.00 and set a “buy” rating on the stock in a research note on Monday, January 29th. Citigroup boosted their price objective on Owens & Minor from $23.00 to $24.00 and gave the company a “neutral” rating in a research note on Wednesday, February 21st. StockNews.com upgraded Owens & Minor from a “hold” rating to a “buy” rating in a research note on Wednesday, February 21st. Finally, Barclays boosted their price objective on Owens & Minor from $21.00 to $23.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 21st. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Owens & Minor has an average rating of “Hold” and an average target price of $23.29.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.